Submit Deal

QUANTA THERAPEUTICS

Summary

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 41 M

Avg. Deal Size£ 41 M

Market Context

Senior Management

Sort

quanta therapeutics

HQ - United States

Biotechnology

22 May 2023

Investment Date

£ 40 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy